Publications by authors named "Nigel Key"

Claim this Profile
A
Activation of the Contact System and Intrinsic Pathway in Peripheral and Portal Venous Circulations in Liver Cirrhosis.
Elena Campello, Alberto Zanetto, Yuriy Prokopenko, Anton Ilich, Chatphatai Moonla, Nigel S Key

Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red cell physiologic stress results in lower quality transfusions: a randomized trial in adults with sickle cell disease.
Matthew S Karafin, Ross M Fasano, Anton Ilich, David Wichlan, Ada Chang, Nigel S Key

Blood Red Cells Iron· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When sickle cell trait is not just trait: risk of VTE.
Rakhi P Naik, Rafal Pawlinski, Nigel S Key

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B.
Steven W Pipe, Wolfgang Miesbach, Michael Recht, Frank W G Leebeek, Nigel S Key

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolysis in a nutshell.
Anton Ilich, Nigel S Key

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia A.
Ming Y Lim, Kristy Lee, Jill M Johnsen, Nigel S Key

Haemophilia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions.
Matthew S Karafin, Abby L Grier, Ross M Fasano, Anton Ilich, David Wichlan, Nigel S Key

J Clin Invest· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study.
Robert Klamroth, Michael Recht, Nigel S Key, Wolfgang Miesbach, Steven W Pipe

Mol Ther Methods Clin Dev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red Blood Cell Extracellular Vesicles as Key Players in Thromboinflammation.
Denis F Noubouossie, Nigel S Key

Semin Thromb Hemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of red cell storage age on transfused patients with sickle cell disease: protocol of a pilot randomized clinical trial to evaluate changes in inflammation and clinical transfusion efficacy.
Matthew S Karafin, Ross M Fasano, Anton Illich, David Wichlan, Ada Chang, Nigel S Key

Blood Transfus· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years.
Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S Key

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model.
Fatima Trebak, Mohammad O Sako, Steven P Grover, Karnsasin Seanoon, Izabela Pawlinski, Nigel S Key

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome" [ Volume 9, Issue 10, October 2024, Pages 3053-3056].
David Massicotte-Azarniouch, Daniel J Crona, Priscilla Karnabi, Bhadran Bose, Patrick H Nachman, Nigel S Key

Kidney Int Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired hemophilia A: a narrative review and management approach in the emicizumab era.
Patrick Ellsworth, Sheh-Li Chen, Lee Ann Jones, Alice D Ma, Nigel S Key

J Thromb Haemost· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype.
Francesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, Alessandro Casini, Giancarlo Castaman, Nigel S Key

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse clinical outcomes associated with sickle cell trait at high altitude.
Katherine A Stafford, Soravis Osataphan, Rushad Patell, Nigel S Key

Haematologica· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Letter: Patient Attitudes Towards Haemophilia Gene Therapy at a US Haemophilia Treatment Center.
Callie Berkowitz, Kristy Lee, Kristi Kirkland, Brenda Nielsen, Patrick Ellsworth, Nigel S Key

Haemophilia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor XIa Inhibitor Reversal in Intracranial Hemorrhage: A Case Report.
Arshed Al-Obeidi, Draia Garavito, Sierra Smalley, Kayla John, Lee Ann Jones, Nigel Key

Neurohospitalist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A-TREAT clinical trial.
Jacqueline N Poston, Siobhan P Brown, Amy Sarah Ginsburg, Anton Ilich, Heather Herren, Nigel S Key

Transfusion· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.
Sonia M Thomas, Robert A Harrington, Clyde W Yancy, Diane Nugent, Serpil Erzurum, Nigel S Key

NEJM Evid· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial.
Andrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, Emily Symington, Doris V Quon, Nigel S Key

Res Pract Thromb Haemost· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertonicity and/or acidosis induce marked rheological changes under hypoxic conditions in sickle trait red blood cells.
Patrick Ellsworth, Izabela J Pawlinski, Rachel Sielaty, Anton Ilich, Yuriy Prokopenko, Nigel S Key

Br J Haematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome.
David Massicotte Azarniouch, Daniel J Crona, Priscilla Karnabi, Bhadran Bose, Patrick H Nachman, Nigel S Key

Kidney Int Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause.
Callie Berkowitz, Alice Ma, Vanessa Miller, Supreet Goraya, Kristi Kirkland, Nigel S Key

Res Pract Thromb Haemost· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data: comment from Berkowitz et al.
Callie Berkowitz, Samuel Wilson, Nigel S Key, Patrick Ellsworth

J Thromb Haemost· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis